The Vanguard Group Discloses Stake in Mural Oncology plc

The Vanguard Group, Inc., a major asset management firm, has filed a Form 8.3 with the Irish Takeover Panel, revealing its stake in Mural Oncology plc. As of August 6, 2025, Vanguard holds 772,339 ordinary shares, representing 4.47% of Mural Oncology's securities. This disclosure aligns with requirements for entities owning 1% or more of relevant securities during a potential takeover.

The filing illustrates Vanguard's current interests and short positions, focusing solely on ordinary shares without involving any cash-settled or stock-settled derivatives. The document clarifies there are no additional agreements or arrangements connected to the voting or future transactions of these securities.

Significantly, Vanguard reported the sale of 32 shares at 1.78 USD each. No indemnity or other dealing arrangements have been noted, ensuring transparency in their holdings within the takeover context.